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Abstract: The aim of this work was to evaluate changes in lymphocyte subpopulations, especially helper and cytotoxic T cells, in
acute brucellosis patients undergoing treatment. Forty-three acute brucellosis patients were included in the study. Twenty healthy
subjects served as controls. Total lymphocytes and the CD3+, CD4+, CD8+, CD19+ and CD (16+56)+ subpopulations were counted by
two-color flow cytometric analysis. The CD4+ counts in patients before and after treatment were not statistically different (p = 0.7),
but healthy subjects had significantly more of these cells (p = 0.001 and p = 0.001 compared to pre- and post-treatment patients,
respectively). The CD8+ counts in acute brucellosis patients decreased after treatment (p = 0.004), but remained higher in both preand post-treatment samples than in healthy subjects (p = 0.001 and p = 0.01 respectively). Neither the total leukocyte counts nor
the numbers of cells in any subpopulation correlated with blood culture results (positive or negative). No statistically significant
differences in the patients’ CD4+ T cell counts were observed between the pre-and post-treatment periods, and the count was higher
in healthy subjects. Counts of CD8+ T cells increased in acute brucellosis patients, and although they decreased after treatment they
remained higher than in the controls. In view of this increase, it was concluded that CD8+ T cells could be the major component in
immunity against brucellosis.
Key Words: lymphocyte subpopulations, brucellosis, treatment.

Introduction
Brucellosis is one of the most important zoonoses
affecting human welfare and livestock health worldwide.
The disease is caused by bacteria of the genus Brucellae,
which comprises several species differing in host affinity
and virulence (1).
Cellular immune responses are a critical part of the
host’s defense against intracellular bacterial infections
(2). The response against Brucellae spp. involves the
whole gamut of the immune system from innate to
adaptive immunity. In brucellosis, the different arms of
the immune system, namely antigen-presenting cells, NK
cells, CD4+ and CD8+ T cells and B cells, act together to
provide a coordinated response (3). However, the
primary mechanism of control involves cell-mediated
immunity rather than antibodies, although some
immunity against re-infection is provided by serum
immunoglobulins (3-5). T-cell counting is the standard
method for evaluating the cellular immune response

against intracellular pathogens. Previous studies on
murine models have shown that cytokine-secreting CD4+
T cells are the fundamental components of immunity
against Brucella. Nevertheless, it is known that CD8+ T
cells are very important in protective immunity (4).
Our aim in this study was to evaluate lymphocyte
subpopulations in acute brucellosis patients during the
pre- and post-treatment periods. We also investigated
whether changes in the numbers of these cells correlated
with blood culture results.

Material and Methods
The forty-three patients included in the study were
admitted to our hospital with fever and musculoskeletal
system dysfunction evidenced by generalized aches and
pains and associated with fatigue, prostration and mental
depression. Clinical and laboratory findings supported a
diagnosis of brucellosis. The control subjects were 20
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healthy persons (11 men and 9 women) with no history
of Brucella infection. The ages of the patients and
controls were 18-64 years (36.42 ± 14.5 years) and 1960 years (36.6 ± 12.8 years) respectively.
The controls had negative STA and 2-ME test results,
showed an erythrocyte sedimentation rate (ESR) within
normal limits and had no complaints. Exclusion criteria
for the healthy control subjects included acute/chronic
diseases, smoking, alcohol consumption, medication,
pregnancy, abnormalities in renal and liver function tests,
and other bacterial infections.
Brucellosis was diagnosed on the basis of clinical,
serological, bacteriological and epidemiological data. The
diagnostic criteria were: isolation of a Brucella species
from blood culture (BACTEC 9050, Becton-Dickinson
Diagnostic Instrument System, Sparks, USA) or a single
Brucella titre of ≥ 1/160 (by a standard tube
agglutination test or Coombs), confirmed by a 2mercaptoethanol (2-ME) test titre of ≥ 1/160, in
association with compatible clinical findings. A 2-ME test
≥ 1/160 suggested ongoing infection. Using the BACTEC
system, Brucellae were cultured and identified. Brucella
species were isolated from the blood cultures in 21 cases
(48.8%). The bacteria were biotyped by H2S production,
urease activity, and a dye sensitivity test (20–40 µg/ml
basic fuchsine and growth in thionine). All the Brucellae
were identified as B. melitensis. Disease activity was
defined by the presence of typical signs and symptoms
and a 2-ME titre ≥ 1/160. The patients’ data were
recorded on prepared forms.
Questionnaires concerning symptoms were completed
by the specialist. Ethical consent was granted by the Local
Ethics Committee. All participants were informed about
the purposes of the study. Before treatment, blood
samples (5 ml) were drawn from all consenting patients
and healthy subjects, treated with EDTA and subjected to
flow cytometry to evaluate the lymphocyte
subpopulations. After isolation of the peripheral
mononuclear cells, a direct immunofluorescence method
was used. Two-color flow-cytometric analysis was
performed on a FACScan flow cytometer (Becton
Dickinson, San Jose, CA) using a Becton Dickinson
Simultest IMK-Lymphocyte kit: CD45/CD14, isotype
control, CD3/CD19, CD3/CD4, CD3/CD8 and
CD3/CD16+56. All lymphocyte subpopulations were
measured in all blood samples by the same method. The
cells were fixed with 1% paraformaldehyde and a total of
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10.000 total events was recorded using CellQuest
software (Becton Dickinson). Each lymphocyte
subpopulation count was expressed as a percentage of the
total number of lymphocytes. Criteria of quality included
a greater than 95% total lymphocyte frequency in the
analysis gate and a homogenous CD45+ population.
Therapy, using one combination of doxycycline plus
rifampin for 45 days, was initiated as soon as the
diagnosis of brucellosis was established. After treatment,
the lymphocyte subpopulations of all the patients were
evaluated again as described above. Responses to
treatment were indicated by (a) improvements in clinical
findings and (b) 2-ME tests with titres ≤ 1/80. Nonresponse to the treatment was identified by ongoing
complaints such as fever, myalgia and other constitutional
symptoms, and by a 2-ME titre ≥ 1/160.
The data were expressed as arithmetic means with
standard deviations. A Mann-Whitney U test for betweengroups, a Wilcoxon Signed Rank Test for in-groups, and
Spearman’s correlation analysis, were all performed using
the SPSS 12.0 packet software. P < 0.05 was considered
statistically significant.

Results
Forty-three patients were included in the study. The
mean ages of the patients and control subjects were
36.42 ± 14.5 years (range 18-64) and 36.6 ± 12.8
(range 19-60) respectively. The patient group consisted
of 19 men and 24 women, and the control subjects
comprised 11 men and 9 women.
The most common mode of disease transmission was
consumption of un-pasteurized cheese and uncooked
meat (51.2%). Symptoms were first noticed between 5
and 75 days after infection (mean ± SD = 24.1 ± 17.3).
Thirty-six patients had fever on admission (83.7%). The
most common complaints were weakness (95.3%),
arthralgia (88.4%), fever (83.7%), sweating (74.4%),
lethargy (48.8%) and headache (46.5). The most
frequently affected organ was the liver, as indicated by
the elevation of liver enzymes in the plasma (21.1%).
Abdominal ultrasonographies revealed splenomegaly and
hepatomegaly in eight (18.6%) and four (9.3%) patients,
respectively. The most commonly affected joints were the
waist and knee (18.6% for both). The physical and
laboratory findings are shown in Table 1.
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Table 1. Physical and laboratory findings in brucellosis patients
Findings

Mean ± Std. Deviation

Temperature on admission
Pulse (per minute)
Hemoglobin (g/dl)
Hematocrit (%)
Erythrocyte sedimentation rate (mm/h)
C- reactive protein (g/dL)
Rheumatoid Factor (g/dL)
White Blood Cell Count (cells/mm3)
*PMNL Count (%)
*Lymphocyte Count (%)
*Monocyte Count (%)
Brucella Standard Tube Agglutination (1/titre)
2-Mercaptoethanol test (1/titer)

37.4 ± 1.1
86.2 ± 7.9
12.6 ± 1.8
36.7 ± 5.2
36.7 ± 29
31.0 ± 26.1
9.2 ± 37.7
6888 ± 2647
51.70 ± 11.07
38.23 ± 11.38
9.30 ± 4.31
344 ± 286
225 ± 196

* In peripheral blood

Total lymphocyte and natural killer (NK) cell counts
were higher in patients both before and after treatment
than in healthy subjects; treatment had no significant
effect on the counts (P > 0.05). In contrast, the CD3+ and
CD8+ cell counts in the patients were higher before than
after treatment, but even after treatment they remained
Table 2.

higher than in the healthy subjects. However, the CD19+
levels and the CD4+/CD8+ ratio were higher in the healthy
subjects than the patients and higher in the patients after
treatment than before. Treatment did not affect the CD4+
cell count but healthy subjects had more of these cells.
These results are summarized in Table 2.
Counts of the T cell population and its subsets in
patients with positive blood cultures were not statistically
different from those with negative blood cultures (Table
3).

Discussion
In most infections, including those by Brucella species,
the different arms of the immune system, namely antigen
presenting cells (APCs), NK, T and B cells, act together to
provide a coordinated response (2). NK cells are part of
the first line of defense against pathogens and following
activation can kill infected targets. However, removal of
NK cells in vivo does not alter the ability of mice to
contend with B. abortus infections. This result shows that
the immune response is sufficient to control Brucella
infection even in the absence of functional NK cells (6). In

Percentages of T cells and subsets, B cells and Natural Killer cells in peripheral blood samples from patients with brucellosis before and
after treatment and from healthy subjects

Total Lymphocyte count

CD3+

CD3+CD4+

CD3+CD8+

CD3+CD4+/CD3+CD8+

CD3-CD19+

CD3-CD(16+56)+

Pre-treatment
Post-treatment
Healthy subjects
Pre-treatment
Post-treatment
Healthy subjects
Pre-treatment
Post-treatment
Healthy subjects
Pre-treatment
Post-treatment
Healthy subjects
Pre-treatment
Post-treatment
Healthy subjects
Pre-treatment
Post-treatment
Healthy subjects
Pre-treatment
Post-treatment
Healthy subjects

N

Mean (%)

SD (%)

P

43
43
20
43
43
20
43
43
20
43
43
20
43
43
20
43
43
20
43
43
20

34.48
34.88
30.13
79.88
77.42
73.24
35.56
36.23
43.36
36.70
32.80
27.17
1.03
1.17
1.69
7.26
10.13
11.86
9.05
10.52
11.03

12.02
10.80
7.65
6.52
6.53
7.14
7.30
7.46
6.01
7.65
7.07
7.01
0.39
0.42
0.47
3.83
3.63
3.26
4.85
5.18
6.70

b
c
a, b
c
b
c
a, b
c
a, b
c
a, b
c

N: number of patients or healthy subjects; SD: standard deviation; a: P < 0.05 between pre- and post-treatment; b: P < 0.05 between pre-treatment and healthy subjects, c: P < 0.05 between post-treatment and healthy subjects.
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Table 3. Counts of T cell population and its subsets in patients with positive and negative blood cultures
Cells

Total Lymphocyte count
CD3+
CD3+CD4+
CD3+CD8+
CD3+CD4+/CD3+CD8+
CD3-CD19+
CD3-CD(16+56)+

Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment

Culture Negative
Mean ± SD

Culture Positive
Mean ± SD

P

34.1 ± 14.1
34.7 ± 12.5
78.1 ± 7.5
75.9 ± 6.8
34.2 ± 5.6
36.0 ± 6.5
36.5 ± 7.2
32.0 ± 7.6
1.0 ± 0.4
1.2 ± 0.5
8.4 ± 4.3
10.7 ± 3.9
9.1 ± 4.8
11.5 ± 6.2

32.15 ± 8.7
33.6 ± 8.12
81.6 ± 5.1
78.5 ± 6.3
37.2 ± 9.2
35.8 ± 7.3
35.9 ± 7.3
32.3 ± 6.8
1.1 ± 0.5
1.2 ± 0.4
6.5 ± 3.3
9.1 ± 3.0
8.7 ± 4.4
10.7 ± 4.3

0.92
0.99
0.13
0.4
0.27
0.78
0.65
0.98
0.28
0.68
0.12
0.32
0.81
0.86

the present study, we observed no differences in NK cell
counts between patients, either before or after
treatment, and healthy subjects. These results are
consistent with the findings described above (6).

the time of diagnosis. They also evaluated the CD3+ and
CD20+ subpopulations in the second month after
treatment and observed no changes during the follow-up
period.

Three main types of mechanisms are involved in the
adaptive immune response in brucellosis. First, IFN-γ
produced by CD4+, CD8+ and γδ T cells activates the
bactericidal activity of the macrophages, hampering the
intracellular survival of Brucella. Second, the cytotoxic
CD8+ and γδ T cells kill the infected macrophages. Third,
Th1-type antibody isotypes such as IgG2a and IgG3
opsonize the pathogen to facilitate phagocytosis. The
significance of CD4+ and/or CD8+ T cells in Brucella
immunity has been controversial. Araya et al. (5)
reported that both T-cell populations are important.
However, Oliveira et al. (7) reported that major
histocompatibility complex (MHC) class I-deficient mice,
which have no CD8+ T cells, control the infection more
slowly than do wild-type mice, while MHC class IIdeficient mice, defective in CD4+ T cells, control the
infection at a similar rate to wild-type mice. These results
suggest that CD8+ T cells play a critical role although, the
role of CD4+ T cells in brucellosis should not be ignored
(3). Moreno-Lafont et al. (8) reported an increase in the
percentage of CD8+ T-cells in the peripheral blood of
patients chronically infected with Brucella spp. In
addition, they found increased numbers of Brucella
antigen-specific CD8+ T cells. Gazapo et al. (9) observed
both a decreased percentage of CD4+ lymphocytes and an
increase in CD8+, hence an inverted CD4+/CD8+ ratio, at

In this study, we found results consistent with many
of the publications mentioned above; peripheral blood
CD8+ T cell counts were higher in patients than in healthy
subjects. In addition, the patients’ CD8+ T cells counts
decreased with treatment. The CD4+/CD8+ ratios were
inverted between the pre- and post-treatment periods.
These findings suggest that the first step in the
development of immunological protection against
brucellosis is an increase in CD8+ T cell numbers. This
contrasts with the findings of Moreno-Lafont et al. (8).
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Many serum passive-transfer experiments suggest
that humoral immunity is significant in murine brucellosis
(10). Hoffmann et al. (11) indicated that high levels of
antibody block the complement-mediated killing of B.
abortus, which would make resistance to the disease
dependent on cell-mediated immunity. Gazapo et al. (9)
indicated that CD20+ cells did not change in brucellosis
patients during the follow-up period. In our study, the
CD19+ cell levels in healthy subjects were significantly
higher than those in acute brucellosis patients; they were
higher before than after treatment in the patients.
We found no literature in English addressing the
correlation between blood culture results and T
lymphocyte subset counts. We found no significant
differences between patients with positive and negative
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blood cultures from the point of view of total T cell and
T-cell subset counts.
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In conclusion, CD8 T cell counts increased in acute
brucellosis. However, these counts decreased after
treatment, though not as far as the levels in healthy
control subjects. The CD4+ T cells counts were higher
than in healthy subjects. CD19+ and NK cell counts
increased after treatment. Blood culture results did not
correlate with the lymphocyte subpopulation counts.
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